Cargando…

HA-1H T-Cell Receptor Gene Transfer to Redirect Virus-Specific T Cells for Treatment of Hematological Malignancies After Allogeneic Stem Cell Transplantation: A Phase 1 Clinical Study

Graft-vs.-leukemia (GVL) reactivity after HLA-matched allogeneic stem cell transplantation (alloSCT) is mainly mediated by donor T cells recognizing minor histocompatibility antigens (MiHA). If MiHA are targeted that are exclusively expressed on hematopoietic cells of recipient origin, selective GVL...

Descripción completa

Detalles Bibliográficos
Autores principales:	van Balen, Peter, Jedema, Inge, van Loenen, Marleen M., de Boer, Renate, van Egmond, H. M., Hagedoorn, Renate S., Hoogstaten, Conny, Veld, Sabrina A. J., Hageman, Lois, van Liempt, P. A. G., Zwaginga, Jaap-Jan, Meij, Pauline, Veelken, H., Falkenburg, J. H. F., Heemskerk, Mirjam H. M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7468382/ https://www.ncbi.nlm.nih.gov/pubmed/32973756 http://dx.doi.org/10.3389/fimmu.2020.01804

Ejemplares similares

P74. A Good Manufacturing Practice procedure to generate therapeutic numbers of highly pure anti-leukaemic virus-specific T-cells
por: van Loenen, MM, et al.
Publicado: (2014)

Extracellular Domains of CD8α and CD8ß Subunits Are Sufficient for HLA Class I Restricted Helper Functions of TCR-Engineered CD4(+) T Cells
por: van Loenen, Marleen M., et al.
Publicado: (2013)

The allogeneic HLA-DP-restricted T-cell repertoire provoked by allogeneic dendritic cells contains T cells that show restricted recognition of hematopoietic cells including primary malignant cells
por: Laghmouchi, Aicha, et al.
Publicado: (2019)

Tracking the progeny of adoptively transferred virus-specific T cells in patients posttransplant using TCR sequencing
por: Huisman, W., et al.
Publicado: (2022)

Reprogramming of Virus-specific T Cells into Leukemia-reactive T Cells Using T Cell Receptor Gene Transfer
por: Heemskerk, Mirjam H.M., et al.
Publicado: (2004)

Promiscuity of Peptides Presented in HLA-DP Molecules from Different Immunogenicity Groups Is Associated With T-Cell Cross-Reactivity
por: Laghmouchi, Aicha, et al.
Publicado: (2022)

CD4 Donor Lymphocyte Infusion Can Cause Conversion of Chimerism Without GVHD by Inducing Immune Responses Targeting Minor Histocompatibility Antigens in HLA Class II
por: van Balen, Peter, et al.
Publicado: (2018)

Magnitude of Off-Target Allo-HLA Reactivity by Third-Party Donor-Derived Virus-Specific T Cells Is Dictated by HLA-Restriction
por: Huisman, Wesley, et al.
Publicado: (2021)

Identification of Functional HLA-A*01:01–Restricted Epstein-Barr Latent Membrane Protein 2–Specific T-Cell Receptors( )
por: Huisman, Wesley, et al.
Publicado: (2020)

Long‐term in vitro persistence of magnetic properties after magnetic bead‐based cell separation of T cells
por: Laghmouchi, Aicha, et al.
Publicado: (2020)

Comparing CAR and TCR engineered T cell performance as a function of tumor cell exposure
por: Wachsmann, Tassilo L. A., et al.
Publicado: (2022)

Human iPSC-derived preclinical models to identify toxicity of tumor-specific T cells with clinical potential
por: van Amerongen, Rosa A., et al.
Publicado: (2023)

Tissue Damage Caused by Myeloablative, but Not Non-Myeloablative, Conditioning before Allogeneic Stem Cell Transplantation Results in Dermal Macrophage Recruitment without Active T-Cell Interaction
por: van Balen, Peter, et al.
Publicado: (2018)

Combining BCMA-targeting CAR T cells with TCR-engineered T-cell therapy to prevent immune escape of multiple myeloma
por: Wachsmann, Tassilo L. A., et al.
Publicado: (2023)

A CD22-reactive TCR from the T-cell allorepertoire for the treatment of acute lymphoblastic leukemia by TCR gene transfer
por: Jahn, Lorenz, et al.
Publicado: (2016)

Generation of CD20-specific TCRs for TCR gene therapy of CD20(low) B-cell malignancies insusceptible to CD20-targeting antibodies
por: Jahn, Lorenz, et al.
Publicado: (2016)

Public T-Cell Receptors (TCRs) Revisited by Analysis of the Magnitude of Identical and Highly-Similar TCRs in Virus-Specific T-Cell Repertoires of Healthy Individuals
por: Huisman, Wesley, et al.
Publicado: (2022)

T cell receptor engineering of primary NK cells to therapeutically target tumors and tumor immune evasion
por: Morton, Laura T, et al.
Publicado: (2022)

Human T cells recognize HLA-DP–bound peptides in two orientations
por: Klobuch, Sebastian, et al.
Publicado: (2022)

DCs redirect T cell traffic
por: Van Epps, Heather L.
Publicado: (2005)

SARS-CoV-2-specific CD4(+) and CD8(+) T cell responses can originate from cross-reactive CMV-specific T cells
por: Pothast, Cilia R, et al.
Publicado: (2022)

Amino acids at position 5 in the peptide/MHC binding region of a public virus‐specific TCR are completely inter‐changeable without loss of function
por: Huisman, Wesley, et al.
Publicado: (2022)

A library of cancer testis specific T cell receptors for T cell receptor gene therapy
por: de Rooij, Marije A.J., et al.
Publicado: (2022)

A library of cancer testis specific T cell receptors for T cell receptor gene therapy
por: de Rooij, Marije A.J., et al.
Publicado: (2023)

PRAME and HLA Class I expression patterns make synovial sarcoma a suitable target for PRAME specific T-cell receptor gene therapy
por: Luk, Sietse J, et al.
Publicado: (2018)

Monoclonal antibody‐mediated killing of tumour cells by neutrophils
por: Heemskerk, Niels, et al.
Publicado: (2018)

A Jurkat 76 based triple parameter reporter system to evaluate TCR functions and adoptive T cell strategies
por: Rosskopf, Sandra, et al.
Publicado: (2018)

Redirecting T-cell Activity with Anti-BCMA/Anti-CD3 Bispecific Antibodies in Chronic Lymphocytic Leukemia and Other B-cell Lymphomas
por: Martens, Anne W.J., et al.
Publicado: (2022)

Loss of the GPI‐anchor in B‐lymphoblastic leukemia by epigenetic downregulation of PIGH expression
por: Loeff, Floris C., et al.
Publicado: (2018)

WT1-specific TCRs directed against newly identified peptides install antitumor reactivity against acute myeloid leukemia and ovarian carcinoma
por: van Amerongen, Rosa A, et al.
Publicado: (2022)

Genetic Redirection of T Cells for the Treatment of Pancreatic Cancer
por: Ali, Aesha I., et al.
Publicado: (2019)

Broadly applicable TCR-based therapy for multiple myeloma targeting the immunoglobulin J chain
por: Meeuwsen, Miranda H., et al.
Publicado: (2023)

Antibody-based redirection of universal Fabrack-CAR T cells selectively kill antigen bearing tumor cells
por: Kuo, Yi-Chiu, et al.
Publicado: (2022)

Comparison of methods generating antibody-epitope conjugates for targeting cancer with virus-specific T cells
por: van der Wulp, Willemijn, et al.
Publicado: (2023)

PRAME and CTCFL-reactive TCRs for the treatment of ovarian cancer
por: van Amerongen, Rosa A., et al.
Publicado: (2023)

Current State of the Art and Prospects of T Cell-Redirecting Bispecific Antibodies in Multiple Myeloma
por: Hosny, Mashhour, et al.
Publicado: (2021)

T‐cell redirecting bispecific antibodies in multiple myeloma: Current landscape and future directions
por: O'Neill, Chloe, et al.
Publicado: (2023)

Novel Redirected T–Cell Immunotherapies for Advanced Prostate Cancer
por: Dorff, Tanya B., et al.
Publicado: (2022)

Sleep disturbances and PTSD: a perpetual circle?
por: van Liempt, Saskia
Publicado: (2012)

T-cell redirecting bispecific and trispecific antibodies in multiple myeloma beyond BCMA
por: van de Donk, Niels W.C.J., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_inpukect7qrkk1rnpq82o4pqii